z-logo
open-access-imgOpen Access
Current role and future direction of osimertinib in epidermal growth factor receptor-mutant non-small cell lung cancer
Author(s) -
ByeongHo Jeong,
SangWon Um
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.12.37
Subject(s) - osimertinib , t790m , epidermal growth factor receptor , lung cancer , medicine , cancer research , mutant , tyrosine kinase , epidermal growth factor , receptor , oncology , biology , gefitinib , erlotinib , genetics , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom